Position in ALT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$324,137
-$68,554 QoQ
Shares Held
106,625
-16.4% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 210 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in ALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. ALT ranks #213 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in ALT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $324,137 | 106,625 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $392,691 | 127,498 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $377,359 | 104,532 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $373,948 | 99,191 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $405,175 | 104,697 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $552,555 | 110,511 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $742,195 | 102,940 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $619,598 | 100,912 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $1,946,851 | 292,760 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $900,287 | 88,437 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,021,443 | 90,795 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $156,852 | 60,328 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $403,097 | 114,192 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $321,078 | 76,085 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $2,946,158 | 179,098 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $8,313,626 | 651,028 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $1,878,703 | 160,573 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,873,216 | 307,589 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $1,699,801 | 185,568 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $617,490 | 54,597 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $140,667 | 14,281 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $169 | 12 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $135 | 12 | Shares | Defined | 2021-02-19 | |
| 2020-06-30 | $139,926 | 13,065 | Shares | Defined | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||